 Phoenix, Arizona--Newsfile Corp. - January 28, 2021 - The Stock Day Podcast welcomed Lexaria Bioscience Corp. NASDAQ: LEXX CSE: LXX the Company, a company with the proprietary drug delivery technology, DehydraTECHTM, which improves the way active pharmaceutical ingredients APIs enter the bloodstream. CEO of the Company, Chris Bunka, joined Stock Day host Everett Jolly. Jolly began the interview by congratulating Bunka on the Companys Nasdaq Capital Market uplisting, which was announced on January 12th, 2021... 